BIVDA Press Releases

15Jan

BIVDA response to Parliament’s vote on the Brexit deal

Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.

Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”

For a copy of BIVDA's position paper on Brexit, click here.

Related

Member Press Release - CRYOcheck™ Lupus Anti-Coagulant Testing

03/02/21   CRYOcheck™ Lupus Anti-Coagulant Testin...

Read More >

BIVDA Statement - Position on proposed validation of COVID Antigen tests for sale in the private sector

BIVDA commentary on proposed validation of COVID Antigen tests for sale in the private sector7th May...

Read More >

BIVDA Press Release - BIVDA welcomes publication of NHS England diagnostics report

 BIVDA welcomes publication of NHS England diagnostics report.  BIVDA has warmly welcomed ...

Read More >

BIVDA Welcomes new EUCOPE – Charles River Associates report on advanced diagnostics

BIVDA Welcomes new EUCOPE – Charles River Associates report on advanced diagnostics  BIVD...

Read More >

Press Release - BIVDA calls for investment in diagnostics to help make Britain a science superpower

BIVDA calls for investment in diagnostics to help make Britain a science superpower BIVDA, the ...

Read More >

External Press Release - Paragon Health UK Based PPE Supplies

Please see attached a press release from Paragon Health regarding UK-manufactured PPE supplies. ...

Read More >